A 1: Most people see modest results (25%), mostly from appetite reduction
For most people, the biggest improvements in performance and longevity still come from: Consistent resistance training Cardiovascular fitness High quality sleep Adequate protein intake Metabolic health Peptides may have a role in selected individuals
ATTAIN-1 (NCT05869903) was a Phase III, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron at various doses to placebo in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease, who did not have diabetes
PROST BIOTECH SDN BHD is not a pharmacy and does not dispense medications
& Gao, X.-M
B12 testing is often performed indiscriminately as part of routine screening and can lead to unnecessary diagnostic and management quandaries